Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
Portfolio · 31 Jul 2026
From the fund’s own N-PORT filingThe fund’s disclosed portfolio, not an index membership list. Showing the largest 25 of 61 positions. The ten largest identified positions carry 48.1% of the portfolio.
| # | Holding | Sector | Country | Weight | Filed value |
|---|---|---|---|---|---|
| 1 | AbbVie, Inc. ABBV | Healthcare | United States | 7.84% | $712.16K |
| 2 | Eli Lilly & Co. LLY | Healthcare | United States | 7.76% | $704.23K |
| 3 | UnitedHealth Group, Inc. UNH | Healthcare | United States | 5.84% | $530.84K |
| 4 | Merck & Co., Inc. MRK | Healthcare | United States | 4.81% | $437.34K |
| 5 | Johnson & Johnson JNJ | Healthcare | United States | 4.81% | $437.33K |
| 6 | AstraZeneca plc AZN | Healthcare | United Kingdom | 3.76% | $341.41K |
Source: SEC filings. Information and analytics, not investment advice.